The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential
Medulloblastoma (MB) is a heterogeneous disease in which survival is highly affected by the underlying subgroup-specific characteristics. Although the current treatment modalities have increased the overall survival rates of MB up to 70–80%, MB remains a major cause of cancer-related mortality among...
Main Authors: | Niek F. H. N. van Bree, Margareta Wilhelm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/20/5009 |
Similar Items
-
REST promotes ETS1‐dependent vascular growth in medulloblastoma
by: Shavali Shaik, et al.
Published: (2021-05-01) -
Medulloblastoma: Immune microenvironment and targeted nano-therapy
by: Qiyue Wang, et al.
Published: (2022-03-01) -
Epigenetics and immune cells in medulloblastoma
by: Francesca Gorini, et al.
Published: (2023-03-01) -
Insights into the Tumor Microenvironment—Components, Functions and Therapeutics
by: Kornélia Baghy, et al.
Published: (2023-12-01) -
Decoding the Roles of Astrocytes and Hedgehog Signaling in Medulloblastoma
by: Terence Teixeira Duarte, et al.
Published: (2021-08-01)